October 07, 2022
Quest Diagnostics Inc. reached a deal with Ravgen Inc. resolving the small biotech business' claims that Quest infringed its prenatal genetic test patents ahead of a trial set to kick off Tuesday in California federal court.
October 06, 2022
Intel is set to argue next week that the Ninth Circuit should revive its suit accusing investment management firm Fortress of breaking antitrust laws by encouraging repeat infringement suits against tech companies in an effort to "monetize meritless patents." Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.